Skip to main content
. 2015 Dec 26;7(4):4048–4061. doi: 10.18632/oncotarget.6767

Figure 3. Detection of ORF2 protein in human cancer cell lines.

Figure 3

(A) Immunoblotting analysis of ORF2p in the indicated cell lines. WI-38, normal fibroblasts; A-375, melanoma; U-87, glioblastoma; HT-29, colon carcinoma; H69, small cell lung carcinoma; BxPC-3, pancreas carcinoma; LnCAP, PC-3 and DU145, prostate carcinoma cell lines (50 μg/lane). α-tubulin served as loading control. (B) Densitometric analysis of ORF2p signal intensity. The data (normalized to α-tubulin) are shown as mean ± S.D. of three independent experiments.